Therapeutic effects of leflunomide, a new antirheumatic drug, on glomerulonephritis induced by the antibasement membrane antibody in rats
- 1 October 1991
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 61 (1), 103-118
- https://doi.org/10.1016/s0090-1229(06)80011-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- PREDNISOLONE AND CHLORAMBUCIL TREATMENT IN IDIOPATHIC MEMBRANOUS NEPHROPATHY WITH DETERIORATING RENAL FUNCTIONThe Lancet, 1988
- Cells and Mediators in GlomerulonephritisNephron, 1988
- Disease modifying activity of HWA 486 in rat adjuvant-induced arthritisInflammation Research, 1987
- Glomerular deposition of cross–linked fibrin in human kidney diseasesKidney International, 1987
- Immunopharmacological profile of HWA 486, a novel isoxazol derivative— II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin AInternational Journal of Immunopharmacology, 1986
- Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1983
- Immunosuppressive Therapy in Rheumatic DiseaseMedical Clinics of North America, 1977
- Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritisArthritis & Rheumatism, 1976
- Induction of Chronic Progressive Glomerulonephritis with Immunofluorescent ‘Mesangial Pattern’ in RatsNephron, 1976
- Production of Nephrotic Syndrome in Rats by Freund's Adjuvants and Rat Kidney Suspensions.Experimental Biology and Medicine, 1959